Live Breaking News & Updates on Roswell Park Care Network

Stay updated with breaking news from Roswell park care network. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Simple Blood Protein Tests Predict Which Lymphoma Patients Are Most Likely to Have Poor CAR T Outcomes

As new cancer treatments become available, some of the most important ongoing research must look at ways to optimize those new approaches so that more patients ....

South-korea , United-states , Seoul , Soult-ukpyolsi , Texas , University-of-florida , Florida , Santa-monica , Houston , New-york , Munich , Bayern

Simple Blood Protein Tests Predict Which Lymphoma Patients Are Most Likely to Have Poor CAR T Outcomes

As new cancer treatments become available, some of the most important ongoing research must look at ways to optimize those new approaches so that more patients ....

United-states , Seoul , Soult-ukpyolsi , South-korea , Santa-monica , Texas , Houston , New-york , Munich , Bayern , Germany , University-of-florida

Roswell Park Study Defines Mechanisms Underlying Promising Precision Therapy for Pancreatic Cancer

A research study led by a multidisciplinary team of scientists at Roswell Park Comprehensive Cancer Center details evidence on the therapeutic efficacy of a com ....

New-york , United-states , American , Agnieszka-witkiewicz , Ethan-abel , Vishnu-kumarasamy , Erik-knudsen , Roswell-park , Prasenjit-dey , Costakis-frangou , Roswell-park-alliance-foundation , Cancer-research

FL118, Drug Candidate Discovered at Roswell Park, Granted FDA Orphan Drug Status for Pancreatic Cancer

The U.S. Food and Drug Administration (FDA) has awarded Orphan Drug Designation to Canget BioTekpharma LLC for FL118, a drug candidate developed at Roswell Park ....

United-states , China , New-york , Chinese , American , Fengzhi-li , Roswell-park , Roswell-park-comprehensive-cancer-center , Drug-administration , Canget-biotekpharma , American-chemical-society-journal-of-medicinal-chemistry , Roswell-park-care-network

Subcutaneous Nivolumab as Effective as IV for Renal Cell Carcinoma — With Much Faster Treatment Time

Subcutaneous injection of the immunotherapy nivolumab (brand name Opdivo) is noninferior to intravenous delivery and dramatically reduces treatment time in pati ....

San-francisco , California , United-states , New-york , American , Saby-george , Roswell-park , Roswell-park-care-network , National-cancer , Roswell-park-comprehensive-cancer-center , Bristol-myers-squibb , American-society-of-clinical-oncology